Time to look beyond just lowering the serum concentration of low density lipoprotein--high density lipoprotein levels are also important.
J R Soc Promot Health
; 121(2): 98-101, 2001 Jun.
Article
em En
| MEDLINE
| ID: mdl-11467215
ABSTRACT
There is convincing epidemiological evidence indicating that the serum levels of high density lipoprotein (HDL) cholesterol are inversely related to the risk of vascular events. Similarly, intervention trials, involving healthy populations and patients with coronary heart disease (CHD), have shown that raising the serum levels of HDL is associated with a significant decrease in the risk of vascular events. It follows that serum HDL levels must be considered when assessing risk and setting therapeutic goals. Some of the currently available national treatment guidelines reflect this view. The present review considers the place of serum HDL measurement in the prevention of vascular events.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Doença das Coronárias
/
Lipoproteínas HDL
/
Lipoproteínas LDL
Tipo de estudo:
Etiology_studies
/
Guideline
/
Risk_factors_studies
Limite:
Humans
País/Região como assunto:
Europa
Idioma:
En
Revista:
J R Soc Promot Health
Assunto da revista:
SAUDE PUBLICA
Ano de publicação:
2001
Tipo de documento:
Article
País de afiliação:
Reino Unido